mianserin has been researched along with Cardiovascular Stroke in 7 studies
Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of mianserin, a tetracyclic antidepressant, and adinazolam, a new triazolobenzodiazepine which has antidepressant activity, on intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation were studied in the dog heart after myocardial infarction and compared to the effects of amitriptyline, a standard tricyclic antidepressant." | 3.68 | Effects of antidepressants on the intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarction. ( Hashimoto, H; Nagashima, S; Nakashima, M; Nishimoto, M; Ozaki, T, 1990) |
| "Treatment with mirtazapine resulted in a non-significant decrease in betaTG and PF4 and platelet 5-HT levels." | 2.71 | Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. ( Crijns, H; Hamulyák, K; Honig, A; Lousberg, R; Scharpé, S; Schins, A; Van Melle, J, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, KW | 1 |
| Burg, MM | 1 |
| Tulner, DM | 1 |
| Smith, OR | 1 |
| Schins, A | 3 |
| de Jonge, P | 3 |
| Quere, M | 1 |
| Delanghe, JR | 1 |
| Crijns, HJ | 2 |
| den Boer, JA | 1 |
| Korf, J | 1 |
| Honig, A | 4 |
| Zuidersma, M | 1 |
| Conradi, HJ | 1 |
| van Melle, JP | 3 |
| Ormel, J | 3 |
| van den Brink, RH | 1 |
| Schene, AH | 2 |
| Lambert, FP | 1 |
| Hamulyák, K | 1 |
| Scharpé, S | 1 |
| Lousberg, R | 1 |
| Van Melle, J | 1 |
| Crijns, H | 1 |
| Kuyper, AM | 1 |
| Tulner, D | 1 |
| Nishimoto, M | 1 |
| Hashimoto, H | 1 |
| Ozaki, T | 1 |
| Nagashima, S | 1 |
| Nakashima, M | 1 |
5 trials available for mianserin and Cardiovascular Stroke
| Article | Year |
|---|---|
Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Inflammation Mediators; M | 2011 |
Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial.
Topics: Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fo | 2013 |
Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: rationale and outline of the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Double-Blind Method; Follow-Up Studie | 2002 |
Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; beta-Thromboglobulin; CD40 Antigen | 2004 |
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events.
Topics: Antidepressive Agents; Cardiovascular Diseases; Cause of Death; Citalopram; Comorbidity; Depressive | 2007 |
2 other studies available for mianserin and Cardiovascular Stroke
| Article | Year |
|---|---|
Implementing an antidepressant treatment strategy for post-MI depression does not reduce risk of further cardiovascular events or mortality.
Topics: Antidepressive Agents; Citalopram; Depressive Disorder, Major; Female; Humans; Male; Mianserin; Myoc | 2013 |
Effects of antidepressants on the intraventricular conduction and the incidence of arrhythmias induced by programmed ventricular stimulation in the dog heart after myocardial infarction.
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents; Arrhythmias, Cardiac; Benzodiaze | 1990 |